OSUR – OraSure Technologies, Inc.
OraSure Technologies, Inc.OSUR
$2.99Name : OraSure Technologies, Inc.
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $231,690,320.00
EPSttm : -0.26
OraSure Technologies, Inc.
$2.99
2.40%$0.07Float Short %
2.88
Margin Of Safety %
-10
Put/Call OI Ratio
0.08
EPS Next Q Diff
EPS Last/This Y
-0.07
EPS This/Next Y
0.27
Price
2.99
Target Price
5
Analyst Recom
2.5
Performance Q
-19.62
Relative Volume
0.82
Beta
0.46
Ticker: OSUR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-20 | OSUR | 3.54 | 0.18 | 0.00 | 2249 |
| 2025-03-21 | OSUR | 3.45 | 0.18 | 0.00 | 2249 |
| 2025-03-24 | OSUR | 3.66 | 0.06 | 0.10 | 1909 |
| 2025-03-25 | OSUR | 3.49 | 0.06 | 0.00 | 1927 |
| 2025-03-26 | OSUR | 3.4 | 0.06 | 0.00 | 1927 |
| 2025-03-27 | OSUR | 3.5 | 0.06 | 0.00 | 1927 |
| 2025-03-28 | OSUR | 3.43 | 0.06 | 0.00 | 1928 |
| 2025-03-31 | OSUR | 3.37 | 0.06 | 0.00 | 1926 |
| 2025-04-01 | OSUR | 3.32 | 0.06 | 0.00 | 1924 |
| 2025-04-02 | OSUR | 3.37 | 0.06 | 999.99 | 1930 |
| 2025-04-03 | OSUR | 3.22 | 0.06 | 0.42 | 1931 |
| 2025-04-04 | OSUR | 3.12 | 0.07 | 999.99 | 1930 |
| 2025-04-07 | OSUR | 3 | 0.08 | 0.00 | 1950 |
| 2025-04-08 | OSUR | 2.93 | 0.08 | 0.00 | 1969 |
| 2025-04-09 | OSUR | 3.15 | 0.07 | 0.00 | 1981 |
| 2025-04-10 | OSUR | 2.94 | 0.06 | 0.00 | 2008 |
| 2025-04-11 | OSUR | 2.92 | 0.06 | 0.00 | 2008 |
| 2025-04-14 | OSUR | 2.99 | 0.06 | 0.00 | 2008 |
| 2025-04-15 | OSUR | 2.93 | 0.06 | 999.99 | 2008 |
| 2025-04-16 | OSUR | 2.92 | 0.07 | 0.27 | 2034 |
| 2025-04-17 | OSUR | 3 | 0.08 | 5.88 | 2041 |
| 2025-04-18 | OSUR | 2.99 | 0.08 | 5.88 | 2041 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-20 | OSUR | 3.54 | -411.9 | - | -0.34 |
| 2025-03-21 | OSUR | 3.45 | -411.9 | - | -0.34 |
| 2025-03-24 | OSUR | 3.66 | -411.9 | - | -0.34 |
| 2025-03-25 | OSUR | 3.49 | -411.9 | - | -0.34 |
| 2025-03-26 | OSUR | 3.39 | -411.9 | - | -0.34 |
| 2025-03-27 | OSUR | 3.49 | -411.9 | - | -0.34 |
| 2025-03-28 | OSUR | 3.43 | -411.9 | - | -0.34 |
| 2025-03-31 | OSUR | 3.37 | -411.9 | - | -0.34 |
| 2025-04-01 | OSUR | 3.32 | -411.9 | - | -0.34 |
| 2025-04-02 | OSUR | 3.37 | -411.9 | - | -0.34 |
| 2025-04-03 | OSUR | 3.22 | -411.9 | - | -0.34 |
| 2025-04-04 | OSUR | 3.12 | -405.6 | - | -0.33 |
| 2025-04-07 | OSUR | 3.01 | -405.6 | - | -0.33 |
| 2025-04-08 | OSUR | 2.93 | -405.6 | - | -0.33 |
| 2025-04-09 | OSUR | 3.16 | -405.6 | - | -0.33 |
| 2025-04-10 | OSUR | 2.94 | -405.6 | - | -0.33 |
| 2025-04-11 | OSUR | 2.92 | -405.6 | - | -0.33 |
| 2025-04-14 | OSUR | 3.00 | -405.6 | - | -0.33 |
| 2025-04-15 | OSUR | 2.93 | -405.6 | - | -0.33 |
| 2025-04-16 | OSUR | 2.93 | -405.6 | - | -0.33 |
| 2025-04-17 | OSUR | 2.99 | -405.6 | - | -0.33 |
| 2025-04-18 | OSUR | 2.99 | -405.6 | - | -0.33 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-20 | OSUR | 7.94 | 0.60 | 3.43 |
| 2025-03-21 | OSUR | 7.94 | 0.60 | 3.43 |
| 2025-03-24 | OSUR | 7.94 | 0.60 | 3.43 |
| 2025-03-25 | OSUR | 7.94 | 0.60 | 3.43 |
| 2025-03-26 | OSUR | 7.94 | 0.60 | 3.16 |
| 2025-03-27 | OSUR | 7.94 | 0.60 | 3.16 |
| 2025-03-28 | OSUR | 7.94 | 0.60 | 3.16 |
| 2025-03-31 | OSUR | 7.94 | 0.66 | 3.16 |
| 2025-04-01 | OSUR | 7.94 | 0.66 | 3.16 |
| 2025-04-02 | OSUR | 7.96 | 0.66 | 3.16 |
| 2025-04-03 | OSUR | 7.96 | 0.66 | 3.16 |
| 2025-04-04 | OSUR | 7.96 | 0.66 | 3.16 |
| 2025-04-07 | OSUR | 7.96 | 0.66 | 3.16 |
| 2025-04-08 | OSUR | 7.96 | 0.66 | 3.16 |
| 2025-04-09 | OSUR | 7.96 | 0.66 | 3.16 |
| 2025-04-10 | OSUR | 7.66 | 0.66 | 2.99 |
| 2025-04-11 | OSUR | 7.66 | 0.66 | 2.88 |
| 2025-04-14 | OSUR | 7.66 | 1.75 | 2.88 |
| 2025-04-15 | OSUR | 7.66 | 1.75 | 2.88 |
| 2025-04-16 | OSUR | 7.66 | 1.75 | 2.88 |
| 2025-04-17 | OSUR | 7.66 | 1.75 | 2.88 |
| 2025-04-18 | OSUR | 7.66 | 1.75 | 2.88 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.1
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
-0.1
Insider Transactions
7.66
Institutional Transactions
1.75
Beta
0.46
Average Sales Estimate Current Quarter
29
Average Sales Estimate Next Quarter
33
Fair Value
2.68
Quality Score
43
Growth Score
40
Sentiment Score
32
Actual DrawDown %
84.9
Max Drawdown 5-Year %
-86.2
Target Price
5
P/E
Forward P/E
PEG
P/S
1.25
P/B
0.54
P/Free Cash Flow
9.83
EPS
-0.26
Average EPS Est. Cur. Y
-0.33
EPS Next Y. (Est.)
-0.06
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-10.49
Relative Volume
0.82
Return on Equity vs Sector %
-24.7
Return on Equity vs Industry %
-13.2
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
OraSure Technologies, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 501
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally. The company's products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, and OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; and Colli-Pee collection devices for the volumetric collection of void urine samples. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, the company develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
stock quote shares OSUR – OraSure Technologies, Inc. Stock Price stock today
news today OSUR – OraSure Technologies, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OSUR – OraSure Technologies, Inc. yahoo finance google finance
stock history OSUR – OraSure Technologies, Inc. invest stock market
stock prices OSUR premarket after hours
ticker OSUR fair value insiders trading